Solutions Case Studies
Download DocumentAventis Builds a Global Registration System
A global R&D network can be a tremendous asset - if the efforts of remote locations are coordinated accessible throughout the organization.
For large companies—particularly companies formed through mergers—establishing the requisite internal integration can pose a challenge.Take the case of Aventis Pharma.
The Aventis ARP system enables scientists working in labs around the world to register chemical information, manage experiments, and access and share accurate informaatin in a consistent fashion.
In this parallel synthesis experiment, a scientist has drawn the generic reaction and set the reactant parameters. After describing the generic reaction, the scientist specifies the actual reactants. Then the ARP system generates the products of the reactions, automatically assigns batch numbers, and displays chemical information, such as molecular weight and formula.
In this parallel synthesis experiment, a scientist has drawn the generic reaction and set the reactant parameters. After describing the generic reaction, the scientist specifies the actual reactants. Then the ARP system generates the products of the reactions, automatically assigns batch numbers, and displays chemical information, such as molecular weight and formula.
When Hoechst Marion Roussel (HMR)and Rhône-Poulenc Rorer (RPR) combined in December 1999, the resulting company had scientists at research labs in three countries, speaking different languages and running multiple systems. In the lab,the scientists employed techniques ranging from classical chemical synthesis to parallel synthesis to combinatorial chemistry. And the teams were in pursuit of breakthroughs in disease areas such as oncology, cardio vascular, infectious diseases, Parkinson's, and Alzheimer's.
To read the complete case study, click the Download Document link near the top of the this article.
